Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

Avgerinos I, Liakos A, Tsapas A, Bekiari E

Diabetes, Metabolic Syndrome and Obesity 2019, 12:2549-2557

Published Date: 3 December 2019